InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: BioInvestor4 post# 75965

Thursday, 05/07/2020 6:46:23 PM

Thursday, May 07, 2020 6:46:23 PM

Post# of 232939
Outstanding quote from Novant's Chief Medical Officer - expanding to severe/critical trial after early experience with mild/moderate.

As "manufacturing, manufacturing, manufacturing" becomes "enrollment, enrollment, enrollment" this is exactly what we need.

"Encouraged by early reports ... in critically ill patients ... under EIND." Sounds like he's responding to Patterson's paper.

Not sure how to think about 400 being screened for the Phase II but only "a number" admitted. Thoughts?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News